- Home
- ICLR vs MEDP Comparison
ICLR vs MEDP Comparison
Compare ICLR & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- MEDP
- Stock Information
- Founded
- ICLR 1990
- MEDP 1992
- Country
- ICLR Ireland
- MEDP United States
- Employees
- ICLR N/A
- MEDP N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ICLR Health Care
- MEDP Health Care
- Exchange
- ICLR Nasdaq
- MEDP Nasdaq
- Market Cap
- ICLR 14.3B
- MEDP 13.4B
- IPO Year
- ICLR 1998
- MEDP 2016
- Fundamental
- Price
- ICLR $160.22
- MEDP $591.27
- Analyst Decision
- ICLR Buy
- MEDP Hold
- Analyst Count
- ICLR 15
- MEDP 12
- Target Price
- ICLR $205.07
- MEDP $465.18
- AVG Volume (30 Days)
- ICLR 903.5K
- MEDP 311.3K
- Earning Date
- ICLR 10-22-2025
- MEDP 10-22-2025
- Dividend Yield
- ICLR N/A
- MEDP N/A
- EPS Growth
- ICLR N/A
- MEDP 25.36
- EPS
- ICLR 7.47
- MEDP 14.32
- Revenue
- ICLR $8,102,602,000.00
- MEDP $2,358,373,000.00
- Revenue This Year
- ICLR N/A
- MEDP $21.48
- Revenue Next Year
- ICLR $0.89
- MEDP $11.90
- P/E Ratio
- ICLR $20.94
- MEDP $41.23
- Revenue Growth
- ICLR N/A
- MEDP 13.88
- 52 Week Low
- ICLR $125.10
- MEDP $250.05
- 52 Week High
- ICLR $228.29
- MEDP $625.00
- Technical
- Relative Strength Index (RSI)
- ICLR 40.05
- MEDP 59.85
- Support Level
- ICLR $155.00
- MEDP $573.07
- Resistance Level
- ICLR $167.43
- MEDP $609.13
- Average True Range (ATR)
- ICLR 5.92
- MEDP 16.87
- MACD
- ICLR -0.53
- MEDP -3.75
- Stochastic Oscillator
- ICLR 32.49
- MEDP 50.88
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.